Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.

Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.

PURPOSE: To assess the relationships of microstructural damage in the cerebral white matter (WM), as measured by diffusion tensor imaging (DTI), with clinical parameters and magnetic resonance imaging (MRI) measures of focal tissue damage in patients with multiple sclerosis (MS). MATERIALS AND METH...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Giorgio, A, Palace, J, Johansen-Berg, H, Smith, S, Ropele, S, Fuchs, S, Wallner-Blazek, M, Enzinger, C, Fazekas, F
Natura:	Journal article
Lingua:	English
Pubblicazione:	2010

Documenti analoghi

Progressive brain tissue loss and reduction of N-acetylaspartate despite immunomodulatory therapy in relapsing-remitting multiple sclerosis: results of a longitudinal single-centre study analysing MR spectroscopic, brain volume and focal tissue changes
di: Enzinger, C, et al.
Pubblicazione: (2005)

A combined longitudinal MRI analysis assessing spectroscopic, brain volume and focal brain tissue changes suggests a limited effect of immunomodulatory agents on the progression of relapsing-remitting multiple sclerosis
di: Enzinger, C, et al.
Pubblicazione: (2004)

Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
di: Marisa Loitfelder, et al.
Pubblicazione: (2014-01-01)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
di: Cifelli, A, et al.
Pubblicazione: (2003)

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.
di: Wylezinska, M, et al.
Pubblicazione: (2003)

BEFORE AND AFTER THE ACUTE MS LESION: A LONGITUDINAL DTI STUDY
di: Giorgio, A, et al.
Pubblicazione: (2009)

Non‐lesional white matter in relapsing–remitting multiple sclerosis assessed by multicomponent T2 relaxation
di: Pietro Bontempi, et al.
Pubblicazione: (2023-12-01)

White matter lesion load and location in relation to cognitive impairment in relapsing–remitting multiple sclerosis
di: Mohammed Y. Ezzeldin, et al.
Pubblicazione: (2024-04-01)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
di: Frank Riemer, et al.
Pubblicazione: (2023-06-01)

Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis
di: Lin Zhao, et al.
Pubblicazione: (2020-07-01)

Interferons in relapsing remitting multiple sclerosis.
di: Goodin, D
Pubblicazione: (2003)

Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients
di: Ángela Bernabéu-Sanz, et al.
Pubblicazione: (2021-03-01)

Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis
di: Christian Kiss, et al.
Pubblicazione: (2024-01-01)

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
di: V. Casado, et al.
Pubblicazione: (2021-07-01)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
di: Wakerley, B, et al.
Pubblicazione: (2011)

Comorbidity in in patients with relapsing-remitting multiple sclerosis
di: O.V. Somilo, et al.
Pubblicazione: (2024-10-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
di: Burcu Altunrende, et al.
Pubblicazione: (2017-12-01)

Advances in the treatment of relapsing - Remitting multiple sclerosis
di: Radu Tanasescu, et al.
Pubblicazione: (2014-04-01)

Postural Control in Relapsing-Remitting Multiple Sclerosis
di: Flavia Salvaterra Cusin, et al.
Pubblicazione: (2022-10-01)

Multiple Sclerosis Relapsing Remitting Progressive Type
di: Nora Fitri, et al.
Pubblicazione: (2020-12-01)

Cognitive impairment in relapsing remitting Multiple Sclerosis
di: Saška Roškar
Pubblicazione: (2003-06-01)

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study.
di: Schmidt, R, et al.
Pubblicazione: (2005)

Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study.
di: Enzinger, C, et al.
Pubblicazione: (2006)

Longitudinal cortex reorganization and white matter tracts structural changes analysis in relapsing-remitting multiple sclerosis patients with hand palsy
di: S. N. Kulikova, et al.
Pubblicazione: (2017-02-01)

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy
di: Foronda Jesus, et al.
Pubblicazione: (2004-06-01)

Behavioural relevance of variation in white matter microstructure.
di: Johansen-Berg, H
Pubblicazione: (2010)

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.
di: Gelineau-Morel, R, et al.
Pubblicazione: (2012)

Developmental changes in white matter microstructure in adolescence
di: Giorgio, A, et al.
Pubblicazione: (2007)

In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis
di: Maria Cellerino, et al.
Pubblicazione: (2023-04-01)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
di: Filippini, G, et al.
Pubblicazione: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
di: Filippini, G, et al.
Pubblicazione: (2003)

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
di: Fernando Rodríguez-Jorge, et al.
Pubblicazione: (2024-11-01)

Oxidative stress in relapsing-remitting multiple sclerosis patients
di: Samaneh Sabouri, et al.
Pubblicazione: (2023-09-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
di: V. M. Alifirova, et al.
Pubblicazione: (2010-08-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
di: Halil Önder
Pubblicazione: (2019-06-01)

Serum prolactin in patients with relapsing remitting multiple sclerosis
di: Hoda A. Alwakil, et al.
Pubblicazione: (2020-07-01)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
di: Burgal María, et al.
Pubblicazione: (2010-04-01)

Mild cognitive impairment in relapsing-remitting multiple sclerosis
di: Dimakopoulou Aikaterini, et al.
Pubblicazione: (2008-04-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
di: VIVIAN M. ANDRADE, et al.
Pubblicazione: (1999-09-01)

Evidence for aetiologic heterogeneity of white matter hyperintensities in the elderly: subanalysis of the Austrian Stroke Prevention Study using lesion probability maps
di: Enzinger, C, et al.
Pubblicazione: (2005)